Loading...
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA
BACKGROUND: Current pharmacological therapies for COPD improve quality of life and symptoms and reduce exacerbations. Given the progressive nature of COPD, it is arguably more important to understand whether the available therapies are able to delay clinical deterioration; the concept of “clinically...
Na minha lista:
| Udgivet i: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6400232/ https://ncbi.nlm.nih.gov/pubmed/30880943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S196383 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|